Abstract
DNA methyltransferase 3B (DNMT3B) mediates gene silencing via epigenetic mechanisms during hepatocellular carcinoma (HCC) progression. We aimed to identify novel targets of DNMT3B and their potential regulatory mechanisms in HCC. Metastasis suppressor 1 (MTSS1) was one of the DNMT3B targets and selected for further study. DNMT3B overexpression was detected in 81.25% of clinical HCC specimens and was negatively associated with MTSS1 in HCC cells and clinical samples. The underlying mechanism by which DNMT3B silences MTSS1 was studied using a combination of methylation-specific polymerase chain reaction (PCR) and bisulfite genome sequencing, chromatin immunoprecipitation-PCR and luciferase reporter assays. We found that the MTSS1 promoter region was sparsely methylated, and the methylation inhibitors failed to abolish DNMT3B-mediated MTSS1 silencing. DNMT3B protein bound directly to the 5′-flanking region (−865/−645) of the MTSS1 gene to inhibit its transcription. The functional role of MTSS1 was investigated using in vitro and in vivo tumorigenicity assays. As a result, MTSS1 exerted tumor suppressor effects and arrested cells in the G2/M phase, but not the G1/S phase of the cell cycle when it was depleted or overexpressed in HCC cells. Taken together, MTSS1, a novel target of DNMT3B, is repressed by DNMT3B via a DNA methylation-independent mechanism. MTSS1 was further characterized as a novel tumor suppressor gene in HCC. These findings highlight how DNMT3B regulates MTSS1, and such data may be useful for the development of new treatment options for HCC.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout






Similar content being viewed by others
Accession codes
Abbreviations
- 5-Aza:
-
5-aza-2′-deoxycytidine
- BGS:
-
bisulfite sequencing
- ChIP:
-
chromatin immunoprecipitation
- DNMTs:
-
DNA methyltransferases
- HCC:
-
hepatocellular carcinoma
- MSP:
-
methylation-specific PCR
- PI:
-
propidium iodide
- qPCR:
-
quantitative real-time PCR
- siRNA:
-
small interfering RNA
- TSG:
-
tumor suppressor gene
References
Bachman KE, Rountree MR, Baylin SB . (2001). Dnmt3a and Dnmt3b are transcriptional repressors that exhibit unique localization properties to heterochromatin. J Biol Chem 276: 32282–32287.
Baylin SB, Herman JG, Graff JR, Vertino PM, Issa JP . (1998). Alterations in DNA methylation: a fundamental aspect of neoplasia. Adv Cancer Res 72: 141–196.
Beaulieu N, Morin S, Chute IC, Robert MF, Nguyen H, MacLeod AR . (2002). An essential role for DNA methyltransferase DNMT3B in cancer cell survival. J Biol Chem 277: 28176–28181.
Bestor TH . (2000). The DNA methyltransferases of mammals. Hum Mol Genet 9: 2395–2402.
Chang DC, Xu N, Luo KQ . (2003). Degradation of cyclin B is required for the onset of anaphase in mammalian cells. J Biol Chem 278: 37865–37873.
Chang HC, Cho CY, Hung WC . (2006). Silencing of the metastasis suppressor RECK by RAS oncogene is mediated by DNA methyltransferase 3b-induced promoter methylation. Cancer Res 66: 8413–8420.
Chen L, Chan TH, Yuan YF, Hu L, Huang J, Ma S et al. (2010). CHD1L promotes hepatocellular carcinoma progression and metastasis in mice and is associated with these processes in human patients. J Clin Invest 120: 1178–1191.
Choi MS, Shim YH, Hwa JY, Lee SK, Ro JY, Kim JS et al. (2003). Expression of DNA methyltransferases in multistep hepatocarcinogenesis. Hum Pathol 34: 11–17.
Claus R, Lubbert M . (2003). Epigenetic targets in hematopoietic malignancies. Oncogene 22: 6489–6496.
Cross FR, Schroeder L, Kruse M, Chen KC . (2005). Quantitative characterization of a mitotic cyclin threshold regulating exit from mitosis. Mol Biol Cell 16: 2129–2138.
Esteller M . (2008). Epigenetics in cancer. N Engl J Med 358: 1148–1159.
Girault I, Tozlu S, Lidereau R, Bieche I . (2003). Expression analysis of DNA methyltransferases 1, 3A, and 3B in sporadic breast carcinomas. Clin Cancer Res 9: 4415–4422.
Gowher H, Jeltsch A . (2002). Molecular enzymology of the catalytic domains of the Dnmt3a and Dnmt3b DNA methyltransferases. J Biol Chem 277: 20409–20414.
Huang XY, Huang ZL, Xu YH, Zhou J, Ye SL, Tang ZY et al. (2010). Effects of MIM-B gene on invasive and metastatic potentials of human hepatocelluar carcinoma MHCC97H cells. Zhonghua Gan Zang Bing Za Zhi 18: 915–919.
Jones PA, Takai D . (2001). The role of DNA methylation in mammalian epigenetics. Science 293: 1068–1070.
Kanai Y, Hirohashi S . (2007). Alterations of DNA methylation associated with abnormalities of DNA methyltransferases in human cancers during transition from a precancerous to a malignant state. Carcinogenesis 28: 2434–2442.
Kaneda M, Okano M, Hata K, Sado T, Tsujimoto N, Li E et al. (2004). Essential role for de novo DNA methyltransferase Dnmt3a in paternal and maternal imprinting. Nature 429: 900–903.
Lee YG, Macoska JA, Korenchuk S, Pienta KJ . (2002). MIM, a potential metastasis suppressor gene in bladder cancer. Neoplasia 4: 291–294.
Linhart HG, Lin H, Yamada Y, Moran E, Steine EJ, Gokhale S et al. (2007). Dnmt3b promotes tumorigenesis in vivo by gene-specific de novo methylation and transcriptional silencing. Genes Dev 21: 3110–3122.
Liu K, Wang G, Ding H, Chen Y, Yu G, Wang J . (2010). Downregulation of metastasis suppressor 1(MTSS1) is associated with nodal metastasis and poor outcome in Chinese patients with gastric cancer. BMC Cancer 10: 428.
Ma S, Guan XY, Lee TK, Chan KW . (2007). Clinicopathological significance of missing in metastasis B expression in hepatocellular carcinoma. Hum Pathol 38: 1201–1206.
McGarvey KM, Greene E, Fahrner JA, Jenuwein T, Baylin SB . (2007). DNA methylation and complete transcriptional silencing of cancer genes persist after depletion of EZH2. Cancer Res 67: 5097–5102.
Mizuno S, Chijiwa T, Okamura T, Akashi K, Fukumaki Y, Niho Y et al. (2001). Expression of DNA methyltransferases DNMT1, 3A, and 3B in normal hematopoiesis and in acute and chronic myelogenous leukemia. Blood 97: 1172–1179.
Nixdorf S, Grimm MO, Loberg R, Marreiros A, Russell PJ, Pienta KJ et al. (2004). Expression and regulation of MIM (Missing In Metastasis), a novel putative metastasis suppressor gene, and MIM-B, in bladder cancer cell lines. Cancer Lett 215: 209–220.
Oh BK, Kim H, Park HJ, Shim YH, Choi J, Park C et al. (2007). DNA methyltransferase expression and DNA methylation in human hepatocellular carcinoma and their clinicopathological correlation. Int J Mol Med 20: 65–73.
Okano M, Bell DW, Haber DA, Li E . (1999). DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell 99: 247–257.
Okano M, Xie S, Li E . (1998). Cloning and characterization of a family of novel mammalian DNA (cytosine-5) methyltransferases. Nat Genet 19: 219–220.
Parr C, Jiang WG . (2009). Metastasis suppressor 1 (MTSS1) demonstrates prognostic value and anti-metastatic properties in breast cancer. Eur J Cancer 45: 1673–1683.
Parry DH, O'Farrell PH . (2001). The schedule of destruction of three mitotic cyclins can dictate the timing of events during exit from mitosis. Curr Biol 11: 671–683.
Potapova TA, Daum JR, Pittman BD, Hudson JR, Jones TN, Satinover DL et al. (2006). The reversibility of mitotic exit in vertebrate cells. Nature 440: 954–958.
Rhee I, Bachman KE, Park BH, Jair KW, Yen RW, Schuebel KE et al. (2002). DNMT1 and DNMT3b cooperate to silence genes in human cancer cells. Nature 416: 552–556.
Robertson KD . (2001). DNA methylation, methyltransferases, and cancer. Oncogene 20: 3139–3155.
Robertson KD, Ait-Si-Ali S, Yokochi T, Wade PA, Jones PL, Wolffe AP . (2000). DNMT1 forms a complex with Rb, E2F1 and HDAC1 and represses transcription from E2F-responsive promoters. Nat Genet 25: 338–342.
Robertson KD, Jones PA . (2000). DNA methylation: past, present and future directions. Carcinogenesis 21: 461–467.
Robertson KD, Keyomarsi K, Gonzales FA, Velicescu M, Jones PA . (2000). Differential mRNA expression of the human DNA methyltransferases (DNMTs) 1, 3a and 3b during the G(0)/G(1) to S phase transition in normal and tumor cells. Nucleic Acids Res 28: 2108–2113.
Roll JD, Rivenbark AG, Jones WD, Coleman WB . (2008). DNMT3b overexpression contributes to a hypermethylator phenotype in human breast cancer cell lines. Mol Cancer 7: 15.
Rountree MR, Bachman KE, Baylin SB . (2000). DNMT1 binds HDAC2 and a new co-repressor, DMAP1, to form a complex at replication foci. Nat Genet 25: 269–277.
Saito Y, Kanai Y, Sakamoto M, Saito H, Ishii H, Hirohashi S . (2001). Expression of mRNA for DNA methyltransferases and methyl-CpG-binding proteins and DNA methylation status on CpG islands and pericentromeric satellite regions during human hepatocarcinogenesis. Hepatology 33: 561–568.
Saito Y, Kanai Y, Sakamoto M, Saito H, Ishii H, Hirohashi S . (2002). Overexpression of a splice variant of DNA methyltransferase 3b, DNMT3b4, associated with DNA hypomethylation on pericentromeric satellite regions during human hepatocarcinogenesis. Proc Natl Acad Sci USA 99: 10060–10065.
Shafiei F, Rahnama F, Pawella L, Mitchell MD, Gluckman PD, Lobie PE . (2008). DNMT3A and DNMT3B mediate autocrine hGH repression of plakoglobin gene transcription and consequent phenotypic conversion of mammary carcinoma cells. Oncogene 27: 2602–2612.
Sigrist S, Jacobs H, Stratmann R, Lehner CF . (1995). Exit from mitosis is regulated by Drosophila fizzy and the sequential destruction of cyclins A, B and B3. EMBO J 14: 4827–4838.
Simao Tde A, Simoes GL, Ribeiro FS, Cidade DA, Andreollo NA, Lopes LR et al. (2006). Lower expression of p14ARF and p16INK4a correlates with higher DNMT3B expression in human oesophageal squamous cell carcinomas. Hum Exp Toxicol 25: 515–522.
Takeshima H, Suetake I, Shimahara H, Ura K, Tate S, Tajima S . (2006). Distinct DNA methylation activity of Dnmt3a and Dnmt3b towards naked and nucleosomal DNA. J Biochem 139: 503–515.
Tao Q, Huang H, Geiman TM, Lim CY, Fu L, Qiu GH et al. (2002). Defective de novo methylation of viral and cellular DNA sequences in ICF syndrome cells. Hum Mol Genet 11: 2091–2102.
Utikal J, Gratchev A, Muller-Molinet I, Oerther S, Kzhyshkowska J, Arens N et al. (2006). The expression of metastasis suppressor MIM/MTSS1 is regulated by DNA methylation. Int J Cancer 119: 2287–2293.
Wang J, Bhutani M, Pathak AK, Lang W, Ren H, Jelinek J et al. (2007). Delta DNMT3B variants regulate DNA methylation in a promoter-specific manner. Cancer Res 67: 10647–10652.
Weisenberger DJ, Velicescu M, Cheng JC, Gonzales FA, Liang G, Jones PA . (2004). Role of the DNA methyltransferase variant DNMT3b3 in DNA methylation. Mol Cancer Res 2: 62–72.
Xu J, Fan H, Zhao ZJ, Zhang JQ, Xie W . (2005). Identification of potential genes regulated by DNA methyltransferase 3B in a hepatocellular carcinoma cell line by RNA interference and microarray analysis. Yi Chuan Xue Bao 32: 1115–1127.
Acknowledgements
This work was supported by The National Natural Science Foundation of China, No. 30971605, and in part by the Dr Cheng Yu Tung Fellowships 2007/08 under the HKU Li Ka Shing Faculty of Medicine. We are grateful to Professor Dianqing WU in UConn Health Center USA for providing siRNA expression vector. We are also grateful to Dr Stephanie Ma in Department of Pathology in University of Hong Kong for helping in MTSS1 antibody.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Supplementary Information accompanies the paper on the Oncogene website
Rights and permissions
About this article
Cite this article
Fan, H., Chen, L., Zhang, F. et al. MTSS1, a novel target of DNA methyltransferase 3B, functions as a tumor suppressor in hepatocellular carcinoma. Oncogene 31, 2298–2308 (2012). https://doi.org/10.1038/onc.2011.411
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/onc.2011.411
Keywords
This article is cited by
-
Portal vein tumor thrombosis in hepatocellular carcinoma: molecular mechanism and therapy
Clinical & Experimental Metastasis (2023)
-
Downregulation of MTSS1 in acute myeloid leukemia is associated with a poor prognosis, chemotherapy resistance, and disease aggressiveness
Leukemia (2021)
-
Role of Akt2 in regulation of metastasis suppressor 1 expression and colorectal cancer metastasis
Oncogene (2017)
-
Comprehensive circular RNA profiling reveals the regulatory role of the circRNA-100338/miR-141-3p pathway in hepatitis B-related hepatocellular carcinoma
Scientific Reports (2017)
-
Mtss1(CSC156) mutant mice fail to display efficient Mtss1 protein depletion
Leukemia (2017)